05.02.17
The American Botanical Council (ABC) welcomed EuroPharma to the growing list of Adopt-an-Herb supporters though its adoption of turmeric (Curcuma longa). By adopting turmeric, EuroPharma helps ABC expand its non-profit educational mission and keep its unique HerbMedPro database updated with the latest scientific and clinical research on this highly popular medicinal plant.
HerbMedPro is a comprehensive, interactive online database that provides access to important scientific and clinical research data on the uses and health effects of approximately 250 herbs.
ABC Founder and Executive Director Mark Blumenthal said: “All of us at ABC are deeply grateful to Terry Lemerond, Cheryl Myers, Lisa Joski, and the entire EuroPharma team for its adoption of turmeric, one of the most popular herbs in today’s market. There is so much scientific and clinical information being published each year on turmeric rhizome and its extracts—a veritable explosion of research findings—that it is quite challenging to keep up with reading and summarizing the literally hundreds of new papers cited in our robust HerbMedPro database.”
EuroPharma’s founder Terry Lemerond praised the Adopt-an-Herb initiative, and said: “Representing turmeric, an herb with such life-changing possibilities and significant clinical studies in the evidence-based database of ABC, is a great alignment with the mission of EuroPharma. We look forward to stewarding the ever-growing scientific and clinical data on this far-reaching herb, which contains the key component curcumin: a compound with an extraordinary scientific profile.”
Turmeric’s adoption page in ABC’s HerbMedPro database can be found here; the HerbMedPro record on turmeric is available here.
The turmeric rhizome has a long history of use in Ayurveda, India’s oldest system of traditional medicine, and in traditional Chinese medicine. Traditionally, turmeric was used internally for indigestion and topically for skin sores and wounds. Many commercially available turmeric extracts are standardized to the level of curcuminoids, a group of biologically active phytochemicals in turmeric, which are collectively known in the marketplace as curcumin (although curcumin is also the name for one of the specific curcuminoids). The anti-inflammatory actions of curcumin may play a large role in its potential therapeutic benefits. Turmeric and curcumin are being investigated in research trials for their ability to treat a range of health conditions such as depression and cognitive decline, and as potential adjunct agents in certain types of cancer.
HerbMedPro is a comprehensive, interactive online database that provides access to important scientific and clinical research data on the uses and health effects of approximately 250 herbs.
ABC Founder and Executive Director Mark Blumenthal said: “All of us at ABC are deeply grateful to Terry Lemerond, Cheryl Myers, Lisa Joski, and the entire EuroPharma team for its adoption of turmeric, one of the most popular herbs in today’s market. There is so much scientific and clinical information being published each year on turmeric rhizome and its extracts—a veritable explosion of research findings—that it is quite challenging to keep up with reading and summarizing the literally hundreds of new papers cited in our robust HerbMedPro database.”
EuroPharma’s founder Terry Lemerond praised the Adopt-an-Herb initiative, and said: “Representing turmeric, an herb with such life-changing possibilities and significant clinical studies in the evidence-based database of ABC, is a great alignment with the mission of EuroPharma. We look forward to stewarding the ever-growing scientific and clinical data on this far-reaching herb, which contains the key component curcumin: a compound with an extraordinary scientific profile.”
Turmeric’s adoption page in ABC’s HerbMedPro database can be found here; the HerbMedPro record on turmeric is available here.
The turmeric rhizome has a long history of use in Ayurveda, India’s oldest system of traditional medicine, and in traditional Chinese medicine. Traditionally, turmeric was used internally for indigestion and topically for skin sores and wounds. Many commercially available turmeric extracts are standardized to the level of curcuminoids, a group of biologically active phytochemicals in turmeric, which are collectively known in the marketplace as curcumin (although curcumin is also the name for one of the specific curcuminoids). The anti-inflammatory actions of curcumin may play a large role in its potential therapeutic benefits. Turmeric and curcumin are being investigated in research trials for their ability to treat a range of health conditions such as depression and cognitive decline, and as potential adjunct agents in certain types of cancer.
